IDEAYA Biosciences (IDYA) Revenue (2020 - 2026)
IDEAYA Biosciences (IDYA) posted Revenue of $6.6 million for Q1 2026, down 39.68% sequentially from $10.9 million in Q4 2025.
IDEAYA Biosciences (IDYA) Revenue (2020 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Revenue for 7 years, with the latest figure at $6.6 million in Q1 2026.
- Quarterly Revenue changed N/A year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $232.3 million (changed N/A YoY) and the FY2025 annual result came in at $218.7 million, up 3024.43% from the prior year.
- Revenue eased to $6.6 million in Q1 2026 per IDYA's latest filing, from $10.9 million in the prior quarter.
- Over five years, Revenue peaked at $207.8 million in Q3 2025 and troughed at $3.5 million in Q2 2023.
- A 5-year average of $25.5 million and a median of $7.4 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue surged 230.87% in 2022, then plunged 72.94% in 2023.
- Over 5 years, Revenue stood at $4.0 million in 2022, then fell by 2.49% to $3.9 million in 2023, then jumped by 78.48% to $7.0 million in 2024, then surged by 55.37% to $10.9 million in 2025, then slumped by 39.68% to $6.6 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $6.6 million, $10.9 million, and $207.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | 8.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.86 Mn |
| Mar 31, 2026 | 6.56 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | 207.83 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 8.04 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 29.70 Mn |
| Jun 30, 2022 | 5.85 Mn |
| Mar 31, 2022 | 11.36 Mn |
| Dec 31, 2021 | 2.96 Mn |
| Sep 30, 2021 | 8.98 Mn |
| Jun 30, 2021 | 8.76 Mn |
| Mar 31, 2021 | 7.25 Mn |
| Dec 31, 2020 | 10.57 Mn |
| Sep 30, 2020 | 8.97 Mn |